{"id":1379,"date":"2026-02-13T19:15:13","date_gmt":"2026-02-13T19:15:13","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/02\/13\/actrims-2026-ultimate-trial-testing-briumvi-in-kids-with-ms-to-launch-soon\/"},"modified":"2026-02-13T19:15:13","modified_gmt":"2026-02-13T19:15:13","slug":"actrims-2026-ultimate-trial-testing-briumvi-in-kids-with-ms-to-launch-soon","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/02\/13\/actrims-2026-ultimate-trial-testing-briumvi-in-kids-with-ms-to-launch-soon\/","title":{"rendered":"ACTRIMS 2026: ULTIMATE trial testing Briumvi in kids with MS to launch soon"},"content":{"rendered":"<p><a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/02\/13\/actrims-2026-ultimate-trials-testing-briumvi-ms-children-enrolling-soon\/\" title=\"ACTRIMS 2026: ULTIMATE trial testing Briumvi in kids with MS to launch soon\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"533\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2026\/02\/iStock-1244933075-800x533.jpg\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"A stethoscope and oral medication packets are seen in front of a blackboard with the words &quot;clinical trial&quot; written on it in all capital letters.\" style=\"margin: auto;margin-bottom: 15px;max-width: 100%\" data-wp-pid=\"159296\" \/><\/a><\/p>\n<p>A clinical trial testing TG Therapeutics&#8216; CD20 inhibitor Briumvi (ublituximab-xiiy) in children with relapsing forms of multiple sclerosis (MS) will begin enrolling participants within the next few months, the developer announced, also unveiling details of the study&#8217;s design. The upcoming Phase 2\/3 trial (NCT07220252) will run in two parallel parts. A Phase 2 portion called [&#8230;]<\/p>\n<p>The post <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/02\/13\/actrims-2026-ultimate-trials-testing-briumvi-ms-children-enrolling-soon\/\">ACTRIMS 2026: ULTIMATE trial testing Briumvi in kids with MS to launch soon<\/a> appeared first on <a href=\"https:\/\/multiplesclerosisnewstoday.com\">Multiple Sclerosis News Today<\/a>.<\/p>\n<p><em>Source: <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/02\/13\/actrims-2026-ultimate-trials-testing-briumvi-ms-children-enrolling-soon\/\" rel=\"nofollow noopener\" target=\"_blank\">multiplesclerosisnewstoday.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A clinical trial testing TG Therapeutics&#8216; CD20 inhibitor Briumvi (ublituximab-xiiy) in children with relapsing forms of multiple sclerosis (MS) will begin enrolling participants within the next few months, the developer announced, also unveiling details of the study&#8217;s design. The upcoming Phase 2\/3 trial (NCT07220252) will run in two parallel parts. A Phase 2 portion called&#8230;<\/p>\n","protected":false},"author":0,"featured_media":1380,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-1379","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1379","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=1379"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1379\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/1380"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=1379"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=1379"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=1379"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}